Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Neumora Therapeutics Inc (NASDAQ: NMRA) is a biotechnology company pioneering precision medicines for brain diseases, leveraging cutting-edge neuroscience and artificial intelligence to develop targeted therapies. With a pipeline focused on neuropsychiatric and neurodegenerative disorders, the company aims to address significant unmet medical needs with data-driven drug discovery. By integrating AI-powered biomarker strategies with innovative therapeutics, Neumora Therapeutics is redefining the future of neuroscience, bringing new hope to patients with complex brain conditions.